Literature DB >> 23380808

Forebrain electrophysiological recording in larval zebrafish.

Scott C Baraban1.   

Abstract

Epilepsy affects nearly 3 million people in the United States and up to 50 million people worldwide. Defined as the occurrence of spontaneous unprovoked seizures, epilepsy can be acquired as a result of an insult to the brain or a genetic mutation. Efforts to model seizures in animals have primarily utilized acquired insults (convulsant drugs, stimulation or brain injury) and genetic manipulations (antisense knockdown, homologous recombination or transgenesis) in rodents. Zebrafish are a vertebrate model system that could provide a valuable alternative to rodent-based epilepsy research. Zebrafish are used extensively in the study of vertebrate genetics or development, exhibit a high degree of genetic similarity to mammals and express homologs for ~85% of known human single-gene epilepsy mutations. Because of their small size (4-6 mm in length), zebrafish larvae can be maintained in fluid volumes as low as 100 μl during early development and arrayed in multi-well plates. Reagents can be added directly to the solution in which embryos develop, simplifying drug administration and enabling rapid in vivo screening of test compounds. Synthetic oligonucleotides (morpholinos), mutagenesis, zinc finger nuclease and transgenic approaches can be used to rapidly generate gene knockdown or mutation in zebrafish. These properties afford zebrafish studies an unprecedented statistical power analysis advantage over rodents in the study of neurological disorders such as epilepsy. Because the "gold standard" for epilepsy research is to monitor and analyze the abnormal electrical discharges that originate in a central brain structure (i.e., seizures), a method to efficiently record brain activity in larval zebrafish is described here. This method is an adaptation of conventional extracellular recording techniques and allows for stable long-term monitoring of brain activity in intact zebrafish larvae. Sample recordings are shown for acute seizures induced by bath application of convulsant drugs and spontaneous seizures recorded in a genetically modified fish.

Entities:  

Mesh:

Year:  2013        PMID: 23380808      PMCID: PMC3582514          DOI: 10.3791/50104

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  13 in total

1.  The use of radiotelemetry to evaluate electrographic seizures in rats with kainate-induced epilepsy.

Authors:  Philip Williams; Andrew White; Damien Ferraro; Suzanne Clark; Kevin Staley; F Edward Dudek
Journal:  J Neurosci Methods       Date:  2006-03-27       Impact factor: 2.390

2.  Pentylenetetrazole induced changes in zebrafish behavior, neural activity and c-fos expression.

Authors:  S C Baraban; M R Taylor; P A Castro; H Baier
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

Review 3.  Zebrafish: an integrative system for neurogenomics and neurosciences.

Authors:  Silke Rinkwitz; Philippe Mourrain; Thomas S Becker
Journal:  Prog Neurobiol       Date:  2010-12-02       Impact factor: 11.685

Review 4.  The zebrafish as a model for human disease.

Authors:  William T Penberthy; Ebrahim Shafizadeh; Shuo Lin
Journal:  Front Biosci       Date:  2002-06-01

5.  Effective targeted gene 'knockdown' in zebrafish.

Authors:  A Nasevicius; S C Ekker
Journal:  Nat Genet       Date:  2000-10       Impact factor: 38.330

6.  Interictal EEG spikes identify the region of electrographic seizure onset in some, but not all, pediatric epilepsy patients.

Authors:  Eric D Marsh; Bradley Peltzer; Merritt W Brown; Courtney Wusthoff; Phillip B Storm; Brian Litt; Brenda E Porter
Journal:  Epilepsia       Date:  2009-09-22       Impact factor: 5.864

7.  Transgenesis in zebrafish with the tol2 transposon system.

Authors:  Maximiliano L Suster; Hiroshi Kikuta; Akihiro Urasaki; Kazuhide Asakawa; Koichi Kawakami
Journal:  Methods Mol Biol       Date:  2009

8.  A large-scale mutagenesis screen to identify seizure-resistant zebrafish.

Authors:  Scott C Baraban; Matthew T Dinday; Peter A Castro; Sally Chege; Stephan Guyenet; Michael R Taylor
Journal:  Epilepsia       Date:  2007-05-23       Impact factor: 5.864

9.  Development and validation of an automated high-throughput system for zebrafish in vivo screenings.

Authors:  Ainhoa Letamendia; Celia Quevedo; Izaskun Ibarbia; Juan M Virto; Olaia Holgado; Maria Diez; Juan Carlos Izpisua Belmonte; Carles Callol-Massot
Journal:  PLoS One       Date:  2012-05-15       Impact factor: 3.240

10.  Mutations affecting development of the zebrafish inner ear and lateral line.

Authors:  T T Whitfield; M Granato; F J van Eeden; U Schach; M Brand; M Furutani-Seiki; P Haffter; M Hammerschmidt; C P Heisenberg; Y J Jiang; D A Kane; R N Kelsh; M C Mullins; J Odenthal; C Nüsslein-Volhard
Journal:  Development       Date:  1996-12       Impact factor: 6.868

View more
  21 in total

1.  Left Habenular Activity Attenuates Fear Responses in Larval Zebrafish.

Authors:  Erik R Duboué; Elim Hong; Kiara C Eldred; Marnie E Halpern
Journal:  Curr Biol       Date:  2017-07-14       Impact factor: 10.834

2.  Ex Vivo Measurement of Electrically Evoked Dopamine Release in Zebrafish Whole Brain.

Authors:  Mimi Shin; Thomas M Field; Chase S Stucky; Mia N Furgurson; Michael A Johnson
Journal:  ACS Chem Neurosci       Date:  2017-06-28       Impact factor: 4.418

3.  Bi-allelic GOT2 Mutations Cause a Treatable Malate-Aspartate Shuttle-Related Encephalopathy.

Authors:  Clara D M van Karnebeek; Rúben J Ramos; Xiao-Yan Wen; Maja Tarailo-Graovac; Joseph G Gleeson; Cristina Skrypnyk; Koroboshka Brand-Arzamendi; Farhad Karbassi; Mahmoud Y Issa; Robin van der Lee; Britt I Drögemöller; Janet Koster; Justine Rousseau; Philippe M Campeau; Youdong Wang; Feng Cao; Meng Li; Jos Ruiter; Jolita Ciapaite; Leo A J Kluijtmans; Michel A A P Willemsen; Judith J Jans; Colin J Ross; Liesbeth T Wintjes; Richard J Rodenburg; Marleen C D G Huigen; Zhengping Jia; Hans R Waterham; Wyeth W Wasserman; Ronald J A Wanders; Nanda M Verhoeven-Duif; Maha S Zaki; Ron A Wevers
Journal:  Am J Hum Genet       Date:  2019-08-15       Impact factor: 11.025

Review 4.  Glial source of nitric oxide in epileptogenesis: A target for disease modification in epilepsy.

Authors:  Shaunik Sharma; Sreekanth Puttachary; Thimmasettappa Thippeswamy
Journal:  J Neurosci Res       Date:  2017-12-12       Impact factor: 4.164

Review 5.  Animal models in epilepsy research: legacies and new directions.

Authors:  Brian P Grone; Scott C Baraban
Journal:  Nat Neurosci       Date:  2015-02-24       Impact factor: 24.884

6.  Trehalose Treatment in Zebrafish Model of Lafora Disease.

Authors:  Stefania Della Vecchia; Asahi Ogi; Rosario Licitra; Francesca Abramo; Gabriele Nardi; Serena Mero; Silvia Landi; Roberta Battini; Federico Sicca; Gian Michele Ratto; Filippo Maria Santorelli; Maria Marchese
Journal:  Int J Mol Sci       Date:  2022-06-20       Impact factor: 6.208

7.  Pharmacological characterization of an antisense knockdown zebrafish model of Dravet syndrome: inhibition of epileptic seizures by the serotonin agonist fenfluramine.

Authors:  Yifan Zhang; Angéla Kecskés; Daniëlle Copmans; Mélanie Langlois; Alexander D Crawford; Berten Ceulemans; Lieven Lagae; Peter A M de Witte; Camila V Esguerra
Journal:  PLoS One       Date:  2015-05-12       Impact factor: 3.240

8.  A Novel Long-term, Multi-Channel and Non-invasive Electrophysiology Platform for Zebrafish.

Authors:  SoonGweon Hong; Philip Lee; Scott C Baraban; Luke P Lee
Journal:  Sci Rep       Date:  2016-06-16       Impact factor: 4.379

9.  Microarray Noninvasive Neuronal Seizure Recordings from Intact Larval Zebrafish.

Authors:  Michaela Meyer; Sameer C Dhamne; Christopher M LaCoursiere; Dimira Tambunan; Annapurna Poduri; Alexander Rotenberg
Journal:  PLoS One       Date:  2016-06-09       Impact factor: 3.240

Review 10.  Function Over Form: Modeling Groups of Inherited Neurological Conditions in Zebrafish.

Authors:  Robert A Kozol; Alexander J Abrams; David M James; Elena Buglo; Qing Yan; Julia E Dallman
Journal:  Front Mol Neurosci       Date:  2016-07-07       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.